A preliminary study released by The Israeli Hayim Sheba Medical Center on the 17th showed that the fourth dose of the new crown vaccine was less effective in resisting the mutated new coronavirus Omiljung strain.
Judging from the infection rate of the Omiljun strain after the fourth dose of the vaccine was given to the medical workers participating in the trial, although the antibody level increased significantly after the fourth dose of the vaccine, the protection provided by this antibody level could only be said to have a certain effect on the Omiljun strain. The researchers pointed out that the Omikejung strain has a certain degree of "resistance" to vaccines.
(Original title: Israel studies a fourth dose of vaccine with poor effectiveness against Aomi Kerong)
Source: Beijing Evening News According to Xinhua News Agency CCTV
Process Edit: U022